E-LIB Suche - Ergebnisse für: Bruin-Weller, Marjolein de

1

526 - Efficacy of upadacitinib vs dupilumab for moderate-to..:

Blauvelt, Andrew ; de Bruin-Weller, Marjolein ; Kwatra, Shawn G...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii28-ii29 , 2024

Link: https://doi.org/10.1093/..

2

Targeted Combined Endpoint Improvement in Patient and Disea..:

Kwatra, Shawn G. ; De Bruin-Weller, Marjolein ; Silverberg, Jonathan I....
Acta Dermato-Venereologica. 104 (2024) - p. adv18452 , 2024

Link: https://doi.org/10.2340/..

3

496 - Conjunctivitis does not increase with longer duration..:

Armstrong, April ; Wollenberg, Andreas ; de Bruin-Weller, Marjolein...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii5-ii6 , 2024

Link: https://doi.org/10.1093/..

4

The pleiotropic role of interleukin-13 in the pathogenesis ..:

Dekkers, Coco ; de Bruin-Weller, Marjolein
British Journal of Dermatology. , 2024

Link: https://doi.org/10.1093/..

5

Dupilumab Consistently Reduces CCL-17 (TARC) in Patients wi..:

Beck, Lisa ; Boguniewicz, Mark ; Kataoka, Yoko...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB14 , 2024

Link: https://doi.org/10.1016/..

6

Practical Management of the JAK1 Inhibitor Abrocitinib for ..:

Gooderham, Melinda J. ; de Bruin-Weller, Marjolein ; Weidinger, Stephan...
Dermatology and Therapy. , 2024

Link: https://doi.org/10.1007/..

7

Lebrikizumab Maintains Improvements in the Patient-Oriented..:

Rosmarin, David ; Wollenberg, Andreas ; Boguniewicz, Mark...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB7 , 2024

Link: https://doi.org/10.1016/..

8

Lebrikizumab Provides Rapid Clinical Responses Across All E..:

Simpson, Eric L. ; de Bruin-Weller, Marjolein ; Hong, H. Chih-ho...
Dermatology and Therapy. 14 (2024) 5 - p. 1145-1160 , 2024

Link: https://doi.org/10.1007/..

9

Influence of pathogenic filaggrin variants on dupilumab tre..:

Clabbers, Julia ; Boesjes, Celeste ; Spekhorst, Lotte...
Journal of Allergy and Clinical Immunology. 153 (2024) 4 - p. 1155-1161.e4 , 2024

Link: https://doi.org/10.1016/..

10

529 - Worsening of itch before flaring in patients with mod..:

Silverberg, Jonathan I ; Kim, Brian S ; de Bruin-Weller, Marjolein...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii31-ii32 , 2024

Link: https://doi.org/10.1093/..

11

Safety of Lebrikizumab in Adults and Adolescents with Moder..:

Stein Gold, Linda ; Thaçi, Diamant ; Thyssen, Jacob P....
American Journal of Clinical Dermatology. 24 (2023) 4 - p. 595-607 , 2023

Link: https://doi.org/10.1007/..

12

Baseline Body Surface Area and Itch Severity Define Respons..:

Thyssen, Jacob P. ; de Bruin-Weller, Marjolein ; Costanzo, Antonio...
Advances in Therapy. 40 (2023) 8 - p. 3574-3587 , 2023

Link: https://doi.org/10.1007/..

13

Safety of baricitinib for the treatment of atopic dermatiti..:

Bieber, Thomas ; Katoh, Norito ; Simpson, Eric L....
Journal of Dermatological Treatment. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

14

44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in ..:

Reich, Kristian ; Silverberg, Jonathan I. ; de Bruin-Weller, Marjolein...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB116 , 2023

Link: https://doi.org/10.1016/..

15

Economic and Humanistic Burden in Paediatric Patients with ..:

Achten, Roselie ; Van der Rijst, Lisa ; Piena, Marjanne...
Acta Dermato-Venereologica. 103 (2023) - p. adv00881 , 2023

Link: https://doi.org/10.2340/..